Moody's Investors Service ("Moody's") commented that Cascades Inc.'s ("Cascades", Ba2 stable) $216 million acquisition of Orchids Paper Products Company ("Orchids", unrated ) is credit positive for Cascades because it will broaden its tissue platform and generate cost synergies. Additionally, the acquisition will allow Cascades to accelerate the modernization of its under-performing tissue asset base while only modestly increasing the company's leverage.